Moreover, therapy of obesity and T2DM with Gly can improve insulin sensitivity [26], increase anti-inflammatory capacity [27], and normalize secretion of triacylglycerol-rich very-low-density lipoproteins from the liver [28]. The gene discussed is INS; the disease is Obesity.